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Abstract
Introduction: The standard therapy for obstructive sleep apnea syndrome (OSAS) is continuous pos-
itive airway pressure (CPAP), but its correct and frequent use is essential to control the disease. 
Purpose: To analyze adherence to CPAP among patients with OSAS treated in a multidisciplinary 
outpatient clinic of a public tertiary hospital. 
Methods: This was a retrospective study evaluating 156 patients with OSAS who underwent 
polysomnography for CPAP titration from 2008 to 2011. The patients were divided into two 
groups, those with good adherence to CPAP (a mean use of four or more hours per night) and 
those with poor adherence. The groups were compared regarding the following data: gender, 
age, body mass index, associated diseases, AHI at diagnostic polysomnography, and pressure 
(cmH2O) suggested by titration polysomnography. 
Results: 125 patients were analyzed, and it was observed that 82 of the patients (65%) had good adher-
ence, whereas 43 (35%) showed poor adherence. Comparison between groups revealed that patients 
with a higher apnea-hypopnea index (AHI) were those who better adhered to treatment with CPAP. 
Conclusions: the rate of adherence to CPAP among OSAS patients undergoing clinical monitor-
ing at a public service was 65%. Patients with a higher AHI were those who adhered better to 
treatment with CPAP.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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Adesão de pacientes com síndrome da apneia obstrutiva do sono à pressão positiva 
contínua em via aérea em um serviço público
Resumo
Introdução: A terapia padrão para tratamento da síndrome da apneia obstrutiva do sono (SAOS) é o 
aparelho de pressão positiva contínua em via aérea (CPAP); todavia, seu uso correto e frequente é 
determinante para o controle da doença. 
Objetivo: Analisar a adesão ao CPAP entre pacientes com SAOS tratados em um ambulatório multi-
disciplinar em um hospital público. 
Please cite this article as: Queiroz DLC, Yui MS, Braga AA, Coelho ML, Küpper DS, Sander HH, et al. Adherence of obstructive sleep apnea 
syndrome patients to continuous positive airway pressure in a public service. Braz J Otorhinolaryngol. 2014;80:126-30.
Institution: Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is currently con-
sidered a public health problem, affecting up to 32.8% of 
the adult population in the city of São Paulo.1 It especially 
affects obese male patients older than 40 years; age and 
body mass index (BMI) are significant risk factors.2
If not appropriately diagnosed and treated, OSAS can 
lead to high morbidity, such as reduced cognitive function3 
and increased risk of accidents, and it is associated with 
diseases such as systemic arterial hypertension,4 metabolic 
syndrome, acute myocardial infarction, and stroke.
Many factors are associated with the complex physiopa-
thology of OSAS. Decreased airway volume, either due to 
craniofacial abnormalities or airway obstruction (adenoton-
sillar hypertrophy, fat deposition in the airways, etc.) has 
been reported, associated with neuromuscular alterations 
in this region. 
The main complaint related to OSAS is excessive day-
time sleepiness (EDS), followed by snoring, increased wei-
ght gain, and excessive nocturnal motor activity. The gold 
standard evaluation to confirm OSAS diagnosis is the poly-
somnography. Continuous positive airway pressure (CPAP) 
equipment is one of the most often employed treatments,5 
since it is non-invasive, low-risk, relatively simple to use, 
and highly effective. Studies have demonstrated that, 
once the patient adheres to treatment, CPAP provides sig-
nificant improvement in quality of life, reduces daytime 
sleepiness and other symptoms,6 and considerably decre-
ases risk factors.4
Although extremely positive, the effects of CPAP beco-
me irrelevant when the patient does not adhere to its regu-
lar use. Poor adherence is a barrier to effective treatment 
of OSAS, as the regular use of CPAP requires a proactive 
patient attitude.6 
Adherence to CPAP is determined by characteristics of 
the disease and the patient, previous titration with the 
equipment, device characteristics and technology, and psy-
chosocial and economic factors.7 Since the nasal interface 
is preferred, nasal resistance and the use of humidifiers are 
also important factors for good treatment adherence.8 Mo-
reover, CPAP treatment should ideally involve a multidisci-
plinary team with physicians, nurses, and physical thera-
pists, among others.9 
Lack of adherence to the main treatment of OSAS is an 
important problem. This study aimed to evaluate CPAP by 
patients followed in the outpatient clinic of sleep respira-
tory disorders in a public service, and to evaluate study va-
riables that might be correlated with poor adherence.
Methods 
According to the protocol of the Outpatient Clinic of Sleep 
Respiratory Disorders of Hospital das Clínicas da Faculdade 
de Medicina de Ribeirão Preto da Universidade de São Paulo, 
patients that receive a diagnosis of OSAS are referred to 
CPAP therapy after undergoing nocturnal polysomnography 
at the Sleep Laboratory, and multidisciplinary clinical as-
sessment by an otolaryngologist, a neurologist, and a pul-
monologist. At this time, OSAS is explained to the patient, 
as well as its causes and its consequences if left untreated. 
Possible and viable therapeutic modalities are defined and, 
if indicated, CPAP is introduced to the patient. The goals of 
treatment are geared towards improving quality of life and 
reducing associated risks. The patient is then referred for 
titration polysomnography and instructed to return to the 
outpatient clinic as soon as the device is available.
Upon return, the device and the mask are verified and 
adjusted to the patient. The patient is instructed regarding 
its use, maintenance, and cleaning, as well as possible ad-
verse effects. Periodic visits are scheduled and the patient 
is instructed to bring the CPAP device for verification of 
maintenance and time of usage, in order to assess adhe-
rence. Practical periodic training is offered to patients who 
have complaints when attempting to optimize device use. 
Patients were considered adherent when they used the de-
vice for a mean period ≥ four hours a night.
This study assessed 156 medical records of patients with 
OSAS, who had undergone titration polysomnography be-
tween 2008 and 2011. Adherence (number of hours of use/
day), anthropometric, and pretreatment polysomnographic 
data, as well as data on the occurrence of associated dise-
ases (especially cardiovascular, pulmonary, and endocrine 
diseases) were retrieved from medical records.  
Only records with complete data were considered for 
analysis. Patients with good adherence (group 1 - mean 
use of four or more hours/night) were compared to pa-
Métodos: Estudo retrospectivo avaliando 156 pacientes com SAOS que foram submetidos à polisso-
nografia para titulação de CPAP de 2008 a 2011. Os pacientes foram divididos em dois grupos: os com 
boa e os com má adesão. Os grupos foram comparados entre si em relação aos seus dados: sexo, 
idade, IMC, doenças associadas, IAH à polissonografia diagnóstica e pressão em (cmH20) sugerida à 
polissonografia de titulação. 
Resultados: Foram analisados 125 pacientes, demonstrando que 82 dels (65%) tinham boa adesão, 
enquanto 43 (35%) eram maus usuários. A comparação entre os grupos mostrou que os pacientes 
com maior índice de apneia e hipopneias (IAH) eram os com melhor adesão ao tratamento com CPAP. 
Conclusões: A taxa de adesão ao CPAP entre os pacientes com SAOS monitorizados regularmente em 
um serviço público foi de 65%. Os pacientes com pior IAH foram os mais aderentes ao tratamento 
com CPAP.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
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tients with poor adherence (group 2 - mean use of less 
than four hours) regarding gender, age, obesity (clini-
cally assessed based on BMI calculated at the first con-
sultation), and presence of comorbidities reported by the 
patient (diabetes, hypertension, and dyslipidemia) by 
Fisher’s exact contingency test. Age, diagnostic apnea-
-hypopnea index (AHI), and CPAP pressure considered to 
be ideal on the day of titration polysomnography were 
compared using Student’s t-test. The level of significance 
was set at p < 0.05 for all analyses.  
This study was approved by the research ethi-
cs committee of the institution, under CAAE number 
06340012.0.0000.5440.
Results 
Of the 156 medical records of patients submitted to titra-
tion polysomnography, 31 were excluded due to incomplete 
data. Of the 125 evaluated patients, 68 reported systemic 
arterial hypertension. Obesity was present in 45 patients, 
28 had diabetes, 17 had dyslipidemia, eight were smokers, 
and eight underwent depression treatment  (Fig. 1). Of the 
analyzed patients, 74 had CPAP indicated for severe OSAS, 
37 for moderate OSAS, 13 for mild OSAS (by patient choice 
or by not being tolerant to any other), and one for pulmo-
nary hypoventilation secondary to neuromuscular disease. 
The mean age was 56.89 ± 16.01 years; 57 patients were 
males and 68 were females.  
All patients were, at the time of initial evaluation, asses-
sed for nasal function, and treated when necessary, either 
clinically (use of topical corticosteroids and saline solution) 
or surgically (septoplasty, with or without turbinectomy). 
None were using a humidifier.
Of the 125 patients, 82 showed good adherence to CPAP 
and 43 had poor adherence. The reported causes of poor 
adherence were leakage (n = 7), problems with the mask 
(n = 7), symptom improvement without CPAP use (n = 4), 
feeling of suffocation (n = 3), dry mouth (n = 2), insomnia 
(n = 2), problems with the device (n = 1), and disturbing the 
partner (n = 1). Fifteen patients gave no justification for not 
making regular use of CPAP. 
Group 1 comprised 82 patients (65%) with a mean age 
of 56.2 ± 15.8 years, while group 2 comprised  43 patients 
(35%) with a mean mean age of 57.9 ± 16.4 years. There was 
no significant difference between the groups (p = 0.57).
The contingency analysis showed no association betwe-
en adherence to CPAP and gender (p > 0.05). There were 
41 males and 41 females in the group of adherent patients. 
Group 2 consisted of 17 men and 27 women. 
The presence of systemic arterial hypertension (45 in 
group 1 vs. 23 in group 2, p > 0.05), diabetes (16 in group 1 
vs. 12 in group 2, p > 0.05), dyslipidemia (13 in group 1 vs. 
four in group 2, p > 0.05), and obesity (31 in group 1 vs. 14 
in group 2, p > 0.05) trended higher in the adherent group, 
with no statistical difference between the groups. 
The mean AHI at diagnosis was 47.7 ± 40.7 for group 1, 
significantly higher (p = 0.04) than that obtained for group 2 
(35.7 ± 25.4), with a mean difference of 12.0 (95% CI: 23.81; 
0.29) (Fig. 2).
The mean CPAP pressure prescribed by titration was 10.3 
± 3.04 cm of water for group 1 and 11.1 ± 7.11 cm of water 
for group 2, with no statistically significant difference be-
tween the groups (p = 0.56) (Fig. 3).
Figure 1 Prevalence of associated diseases in patients with ob-
structive sleep apnea syndrome (OSAS) using continuous positive 
airway pressure (CPAP).
Figure 2 Comparison of apnea-hypopnea index (AHI) between 
patients with and without good adherence to continuous positive 
airway pressure. Analyzed by Student’s t-test, considered statisti-
cally significant when p < 0.05. 
Figure 3 Comparison of pressure considered ideal for titration (in 
cm H2O) between patients with and without good adherence to 
continuous positive airway pressure (CPAP). Analyzed by Student’s 
t-test, considered statistically significant when p < 0.05. 
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events associated with cognitive complaints, hypertension, 
type 2 diabetes mellitus, acute myocardial infarction, and 
metabolic syndrome.8
Many studies have confirmed that the use of CPAP objec-
tively improves AHI and sleepiness symptoms.10-12 However, 
despite the proven benefits of its use, adherence rates are 
problematic. Matthews et al.10 reported that 15% to 30% 
of patients reject CPAP at the start of treatment, and that 
the rate of long-term adherence is, on average, 50%. Other 
authors13-18 have reported that adherence to CPAP ranges 
from 28% to 83%, and that adherence tends to decrease with 
time, especially in cases where the patient is not followe-
d-up regularly. According to them, one of the main factors 
that influence adherence is patient instruction on the cor-
rect use of the device when the patient first acquires it and 
periodic follow-up to confirm that the patient is using it, as 
well as to correct any errors or answer any questions that 
might arise in that period. 
In the present study, the rate of adherence was 65%, af-
ter a minimum of one year of use. This relatively good result 
was probably because patients were trained and instructed 
on the importance of using the equipment to improve qua-
lity of life and to reduce risk factors, in addition to periodic 
returns for device maintenance and verification of the hour 
meter, even when the patient has been adherent to the de-
vice for a long period of time.
There is no consensus on the influence of demographic 
data on adherence to CPAP. In the present study, no influen-
ce of gender was observed on CPAP adherence, which is in 
agreement with the results reported by Budhiraja et al.19 
However, there was a predominance of women among pa-
tients who brought the CPAP to the clinic, despite the clear 
predominance of OSAS in men. Villar et al.20 reported bet-
ter adherence to CPAP among women. 
Moreover, no influence of age was observed on adherence 
to CPAP, while Villar et al.20 reported that younger patients of 
lower socioeconomic level had poorer adherence to the devi-
ce. This discrepancy between the results can be explained by 
the fact that the population of the present study did not inclu-
de very young patients, who probably have the poorest adhe-
rence. The influence of socioeconomic factors on the purchase 
of the device was minimized in the present study due to an 
agreement between the Hospital, the Regional Department of 
Health, and the Municipal Governments of DRSXIII - São Paulo, 
Brazil, in which the latter rent the equipment for the patients 
and pay for the treatment, when it is indicated. 
It is reasonable to assume that the more symptomatic 
patients are those who show better adherence to treat-
ment. Studies on adherence to CPAP have suggested that 
patients with worse AHI would show better adherence to 
treatment.8,21 The present study, as well as the study by 
Wild et al.,22 confirmed this suspicion. It could be specula-
ted that patients with worse AHI are more adherent because 
they are more symptomatic and are especially concerned 
with developing associated diseases. 
Shapiro et al.13 reported that BMI and AHI are predic-
tive of better adherence to CPAP. However, no association 
between treatment adherence and obesity was observed in 
the present study.
CPAP treatment is important in reducing the risk of pos-
sible diseases associated with OSAS. However, adherence 
to the equipment remains a therapeutic challenge. In this 
sense, continued patient education and follow-up by a mul-
tidisciplinary team should be encouraged in specialized cen-
ters for the treatment of patients with OSAS. 
Conclusion
Approximately two-thirds of the studied patients adequa-
tely adhered to CPAP therapy in a center where a multidisci-
plinary team provides continuous and long-term monitoring 
to patients. An association was observed between adheren-
ce to CPAP and intensity of AHI, and patients with more se-
vere apnea showed better adherence. 
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